18-325 - A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Status: open


A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of INCB001158 in Combination With Chemotherapy, in Subjects With Advanced or Metastatic Solid Tumors

Treatment for Solid Tumors

Contact Us Or call (251) 445-9834

Description


The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.

Sponsors

This trial is sponsored by Incyte Corporation.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.